List of Tables
Table 1. Global Cancer Tumor Profiling Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Next-generation Sequencing (NGS)
Table 3. Key Players of Polymerase Chain Reaction (PCR)
Table 4. Key Players of Immunohistochemistry (IHC)
Table 5. Key Players of In Situ Hybridization (ISH)
Table 6. Key Players of Microarray
Table 7. Key Players of Others
Table 8. Global Cancer Tumor Profiling Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Cancer Tumor Profiling Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Cancer Tumor Profiling Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Cancer Tumor Profiling Market Share by Region (2019-2024)
Table 12. Global Cancer Tumor Profiling Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Cancer Tumor Profiling Market Share by Region (2025-2030)
Table 14. Cancer Tumor Profiling Market Trends
Table 15. Cancer Tumor Profiling Market Drivers
Table 16. Cancer Tumor Profiling Market Challenges
Table 17. Cancer Tumor Profiling Market Restraints
Table 18. Global Cancer Tumor Profiling Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Cancer Tumor Profiling Market Share by Players (2019-2024)
Table 20. Global Top Cancer Tumor Profiling Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Tumor Profiling as of 2023)
Table 21. Ranking of Global Top Cancer Tumor Profiling Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Cancer Tumor Profiling Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Cancer Tumor Profiling Product Solution and Service
Table 25. Date of Enter into Cancer Tumor Profiling Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Cancer Tumor Profiling Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Cancer Tumor Profiling Revenue Market Share by Type (2019-2024)
Table 29. Global Cancer Tumor Profiling Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Cancer Tumor Profiling Revenue Market Share by Type (2025-2030)
Table 31. Global Cancer Tumor Profiling Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Cancer Tumor Profiling Revenue Market Share by Application (2019-2024)
Table 33. Global Cancer Tumor Profiling Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Cancer Tumor Profiling Revenue Market Share by Application (2025-2030)
Table 35. North America Cancer Tumor Profiling Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Cancer Tumor Profiling Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Cancer Tumor Profiling Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Cancer Tumor Profiling Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Cancer Tumor Profiling Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Cancer Tumor Profiling Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Cancer Tumor Profiling Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Cancer Tumor Profiling Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Cancer Tumor Profiling Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Cancer Tumor Profiling Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Cancer Tumor Profiling Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Cancer Tumor Profiling Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Cancer Tumor Profiling Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Cancer Tumor Profiling Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Cancer Tumor Profiling Market Size by Country (2025-2030) & (US$ Million)
Table 50. Qiagen N.V. Company Detail
Table 51. Qiagen N.V. Business Overview
Table 52. Qiagen N.V. Cancer Tumor Profiling Product
Table 53. Qiagen N.V. Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 54. Qiagen N.V. Recent Development
Table 55. Roche Molecular Systems Inc. Company Detail
Table 56. Roche Molecular Systems Inc. Business Overview
Table 57. Roche Molecular Systems Inc. Cancer Tumor Profiling Product
Table 58. Roche Molecular Systems Inc. Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 59. Roche Molecular Systems Inc. Recent Development
Table 60. Abott Molecular Company Detail
Table 61. Abott Molecular Business Overview
Table 62. Abott Molecular Cancer Tumor Profiling Product
Table 63. Abott Molecular Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 64. Abott Molecular Recent Development
Table 65. Illumina Inc. Company Detail
Table 66. Illumina Inc. Business Overview
Table 67. Illumina Inc. Cancer Tumor Profiling Product
Table 68. Illumina Inc. Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 69. Illumina Inc. Recent Development
Table 70. NeoGenomics Laboratories Company Detail
Table 71. NeoGenomics Laboratories Business Overview
Table 72. NeoGenomics Laboratories Cancer Tumor Profiling Product
Table 73. NeoGenomics Laboratories Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 74. NeoGenomics Laboratories Recent Development
Table 75. HTG Molecular Diagnostic Company Detail
Table 76. HTG Molecular Diagnostic Business Overview
Table 77. HTG Molecular Diagnostic Cancer Tumor Profiling Product
Table 78. HTG Molecular Diagnostic Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 79. HTG Molecular Diagnostic Recent Development
Table 80. Genomic Health Inc. Company Detail
Table 81. Genomic Health Inc. Business Overview
Table 82. Genomic Health Inc. Cancer Tumor Profiling Product
Table 83. Genomic Health Inc. Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 84. Genomic Health Inc. Recent Development
Table 85. Hologic Gen-Probe Company Detail
Table 86. Hologic Gen-Probe Business Overview
Table 87. Hologic Gen-Probe Cancer Tumor Profiling Product
Table 88. Hologic Gen-Probe Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 89. Hologic Gen-Probe Recent Development
Table 90. BD Biosciences Company Detail
Table 91. BD Biosciences Business Overview
Table 92. BD Biosciences Cancer Tumor Profiling Product
Table 93. BD Biosciences Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 94. BD Biosciences Recent Development
Table 95. Siemens Healthineers Company Detail
Table 96. Siemens Healthineers Business Overview
Table 97. Siemens Healthineers Cancer Tumor Profiling Product
Table 98. Siemens Healthineers Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 99. Siemens Healthineers Recent Development
Table 100. Claris Life Sciences Company Detail
Table 101. Claris Life Sciences Business Overview
Table 102. Claris Life Sciences Cancer Tumor Profiling Product
Table 103. Claris Life Sciences Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 104. Claris Life Sciences Recent Development
Table 105. Personal Genome Diagnostics, Inc. Company Detail
Table 106. Personal Genome Diagnostics, Inc. Business Overview
Table 107. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Product
Table 108. Personal Genome Diagnostics, Inc. Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 109. Personal Genome Diagnostics, Inc. Recent Development
Table 110. Perthera, Inc. Company Detail
Table 111. Perthera, Inc. Business Overview
Table 112. Perthera, Inc. Cancer Tumor Profiling Product
Table 113. Perthera, Inc. Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 114. Perthera, Inc. Recent Development
Table 115. Foundation Medicine, Inc Company Detail
Table 116. Foundation Medicine, Inc Business Overview
Table 117. Foundation Medicine, Inc Cancer Tumor Profiling Product
Table 118. Foundation Medicine, Inc Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 119. Foundation Medicine, Inc Recent Development
Table 120. V., Strand Company Detail
Table 121. V., Strand Business Overview
Table 122. V., Strand Cancer Tumor Profiling Product
Table 123. V., Strand Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 124. V., Strand Recent Development
Table 125. ApoCell Company Detail
Table 126. ApoCell Business Overview
Table 127. ApoCell Cancer Tumor Profiling Product
Table 128. ApoCell Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 129. ApoCell Recent Development
Table 130. Contextual Genomics Company Detail
Table 131. Contextual Genomics Business Overview
Table 132. Contextual Genomics Cancer Tumor Profiling Product
Table 133. Contextual Genomics Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 134. Contextual Genomics Recent Development
Table 135. Agendia Company Detail
Table 136. Agendia Business Overview
Table 137. Agendia Cancer Tumor Profiling Product
Table 138. Agendia Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 139. Agendia Recent Development
Table 140. GenScript Company Detail
Table 141. GenScript Business Overview
Table 142. GenScript Cancer Tumor Profiling Product
Table 143. GenScript Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 144. GenScript Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Tumor Profiling Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Cancer Tumor Profiling Market Share by Type: 2023 VS 2030
Figure 3. Next-generation Sequencing (NGS) Features
Figure 4. Polymerase Chain Reaction (PCR) Features
Figure 5. Immunohistochemistry (IHC) Features
Figure 6. In Situ Hybridization (ISH) Features
Figure 7. Microarray Features
Figure 8. Others Features
Figure 9. Global Cancer Tumor Profiling Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Cancer Tumor Profiling Market Share by Application: 2023 VS 2030
Figure 11. Personalized Medicine Case Studies
Figure 12. Diagnostics Case Studies
Figure 13. Biomarker Discovery Case Studies
Figure 14. Prognostics Case Studies
Figure 15. Research Applications Case Studies
Figure 16. Cancer Tumor Profiling Report Years Considered
Figure 17. Global Cancer Tumor Profiling Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global Cancer Tumor Profiling Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Cancer Tumor Profiling Market Share by Region: 2023 VS 2030
Figure 20. Global Cancer Tumor Profiling Market Share by Players in 2023
Figure 21. Global Top Cancer Tumor Profiling Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Tumor Profiling as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Cancer Tumor Profiling Revenue in 2023
Figure 23. North America Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Cancer Tumor Profiling Market Share by Country (2019-2030)
Figure 25. United States Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Cancer Tumor Profiling Market Share by Country (2019-2030)
Figure 29. Germany Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Cancer Tumor Profiling Market Share by Region (2019-2030)
Figure 37. China Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Japan Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. South Korea Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. India Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Australia Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Cancer Tumor Profiling Market Share by Country (2019-2030)
Figure 45. Mexico Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Brazil Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Cancer Tumor Profiling Market Share by Country (2019-2030)
Figure 49. Turkey Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Qiagen N.V. Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 52. Roche Molecular Systems Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 53. Abott Molecular Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 54. Illumina Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 55. NeoGenomics Laboratories Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 56. HTG Molecular Diagnostic Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 57. Genomic Health Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 58. Hologic Gen-Probe Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 59. BD Biosciences Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 60. Siemens Healthineers Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 61. Claris Life Sciences Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 62. Personal Genome Diagnostics, Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 63. Perthera, Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 64. Foundation Medicine, Inc Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 65. V., Strand Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 66. ApoCell Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 67. Contextual Genomics Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 68. Agendia Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 69. GenScript Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed